DGB

(2E)-N-{4-[1-(benzenecarbonyl)piperidin-4-yl]butyl}-3-(pyridin-3-yl)prop-2-enamide

Find entries where: DGB

is present as a standalone ligand in 4 entries

Find related ligands:

Chemical Component Summary
Name	(2E)-N-{4-[1-(benzenecarbonyl)piperidin-4-yl]butyl}-3-(pyridin-3-yl)prop-2-enamide
Synonyms	FK-866
Identifiers	(E)-N-[4-[1-(phenylcarbonyl)piperidin-4-yl]butyl]-3-pyridin-3-yl-prop-2-enamide
Formula	C₂₄ H₂₉ N₃ O₂
Molecular Weight	391.506
Type	NON-POLYMER
Isomeric SMILES	c1ccc(cc1)C(=O)N2CCC(CC2)CCCCNC(=O)/C=C/c3cccnc3
InChI	InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+
InChIKey	KPBNHDGDUADAGP-VAWYXSNFSA-N

Chemical Details
Formal Charge	0
Atom Count	58
Chiral Atom Count	0
Bond Count	60
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB12731
Name	Daporinad
Groups	investigational
Description	Daporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.
Synonyms	Daporinad
Categories	Acids, Acyclic Acrylates Amides
CAS number	658084-64-1

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Nicotinamide phosphoribosyltransferase	MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLR...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682